Dr Agarwals Health Care Ltd

Dr Agarwal's Hea Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Dr Agarwals Health Care Ltd

₹ 478 -0.87%
31 Jul - close price
dragarwals.co.in BSE: 544350 NSE: AGARWALEYE
About

Incorporated in 2010,[1]Dr. Agarwal’s Health Care offers a wide array of eye care services, which include cataract and refractive surgeries, consultations, diagnoses, and non-surgical treatments. Additionally, they provide optical products, contact lenses, accessories, and pharmaceutical items related to eye care. [2]

Key Points

Largest Eyecare Service Provider:[1][2]
Dr. Agarwal is India's largest eye care
service chain with a 26-27% market share.
It is the largest company by revenue in FY25, witnessed faster growth than other organized eye care service market.

Website BSE NSE
  • Market Cap ₹ 15,154 Cr.
  • Current Price ₹ 478
  • High / Low ₹ 568 / 401
  • Stock P/E 352
  • Book Value ₹ 62.9
  • Dividend Yield 0.00 %
  • ROCE 5.58 %
  • ROE 2.19 %
  • Face Value ₹ 1.00
Edit ratios

Pros

Cons

  • Stock is trading at 7.60 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has low interest coverage ratio.
  • Company has a low return on equity of 1.79% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE Healthcare Nifty Microcap 250 Nifty Total Market BSE 1000 BSE Hospitals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
213 225 240 255 268 281 302 309 335 348
158 157 190 198 203 208 235 240 255 256
Operating Profit 55 67 49 58 65 73 67 69 80 92
OPM % 26% 30% 21% 23% 24% 26% 22% 22% 24% 26%
13 13 2 5 10 24 12 6 6 1
Interest 22 22 23 23 23 21 19 17 18 19
Depreciation 32 35 37 38 39 42 44 48 48 56
Profit before tax 15 24 -8 1 12 34 16 10 20 18
Tax % 37% 29% 5% 746% 37% 22% 35% 51% 31% 42%
10 17 -9 -4 8 27 10 5 14 11
EPS in Rs 0.25 0.84 0.32 0.15 0.44 0.33
Raw PDF
Upcoming result date: 4 August 2026

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
202 248 232 362 598 835 1,044 1,293
186 202 199 275 436 611 795 986
Operating Profit 16 46 33 86 162 224 249 308
OPM % 8% 19% 14% 24% 27% 27% 24% 24%
5 9 4 10 -12 38 40 26
Interest 20 42 34 38 64 88 94 73
Depreciation 21 49 55 59 92 129 156 197
Profit before tax -20 -36 -52 -1 -6 45 39 64
Tax % 0% 0% 4% 55% -641% 47% 43% 38%
-20 -36 -54 -1 32 24 22 39
EPS in Rs 0.69 1.25
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 41%
3 Years: 29%
TTM: 24%
Compounded Profit Growth
10 Years: %
5 Years: 23%
3 Years: -9%
TTM: 108%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 6%
Return on Equity
10 Years: %
5 Years: 3%
3 Years: 2%
Last Year: 2%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 7 7 7 7 8 9 32 32
Reserves 290 248 194 192 554 1,218 1,902 1,960
135 142 161 252 590 661 568 670
60 200 281 242 236 298 335 300
Total Liabilities 492 596 643 692 1,388 2,187 2,837 2,961
99 322 387 367 907 1,302 1,591 1,922
CWIP 1 3 11 2 35 9 18 29
Investments 238 146 121 147 187 629 729 615
154 124 124 176 258 248 498 395
Total Assets 492 596 643 692 1,388 2,187 2,837 2,961

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
40 46 78 153 222 208 321
-37 -26 -98 -436 -818 -577 -167
-60 -21 40 316 570 374 -173
Net Cash Flow -56 -1 20 33 -26 5 -19
Free Cash Flow -91 23 12 76 87 18 6
CFO/OP 94% 147% 94% 102% 105% 81% 115%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 46 46 39 31 24 22 25 23
Inventory Days 138 159 147 149 119 135 174 66
Days Payable 330 427 608 456 354 383 375 122
Cash Conversion Cycle -147 -222 -422 -276 -210 -226 -176 -32
Working Capital Days 5 -37 -43 -54 -88 -79 -55 -21
ROCE % 1% -5% 9% 10% 8% 6% 6%

Insights

In beta
Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash Payor Mix
%

Log in to view insights

Please log in to see hidden values.

Login
Cataract Surgeries Performed
#
Number of Doctors
#
Number of Emerging Facilities
#
Number of International Facilities
#
Number of Patients Served
#
Total Number of Facilities
#
Total Surgeries Performed
#

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
32.45% 32.43% 32.43% 32.39% 32.35% 32.34%
60.62% 59.26% 58.13% 58.06% 57.94% 57.97%
5.21% 6.44% 7.92% 7.78% 7.83% 7.72%
1.74% 1.87% 1.52% 1.78% 1.87% 1.97%
No. of Shareholders 68,69663,02148,16846,55443,53842,492

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls